Minna Chen

Shantou, 515031, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Resistance mechanisms and post-trastuzumab deruxtecan (T-DXd) strategies in HER2+ and HER2-low breast cancer: From biology to clinical practice.

Resistance mechanisms and post-trastuzumab deruxtecan (T-DXd) strategies in HER2+ and HER2-low breast cancer: From biology to clinical practice.

Journal: Critical reviews in oncology/hematology

Published: September 04, 2025

Human endogenous retrovirus ERVK3-1 characterizes a metabolically active and immunosuppressive subtype of liver cancer.

Human endogenous retrovirus ERVK3-1 characterizes a metabolically active and immunosuppressive subtype of liver cancer.

Journal: Virology journal

Published: June 04, 2025

Cyclophosphamide for severe T-DXd-induced interstitial lung disease in low-HER2 breast cancer: a case report and mechanistic insights.

Cyclophosphamide for severe T-DXd-induced interstitial lung disease in low-HER2 breast cancer: a case report and mechanistic insights.

Journal: Frontiers in oncology

Published: May 30, 2025

Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report.

Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report.

Journal: Frontiers in immunology

Published: March 11, 2025

Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications.

Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications.

Journal: Hereditas

Published: March 07, 2025

Machine learning based intratumor heterogeneity related signature for prognosis and drug sensitivity in breast cancer.

Machine learning based intratumor heterogeneity related signature for prognosis and drug sensitivity in breast cancer.

Journal: Scientific reports

Published: January 13, 2025

Disulfidptosis, a novel regulated cell death to predict survival and therapeutic response in kidney renal clear cell carcinoma.

Disulfidptosis, a novel regulated cell death to predict survival and therapeutic response in kidney renal clear cell carcinoma.

Journal: Discover oncology

Published: November 01, 2024

A longitudinal and cross-sectional study of placental circulation between normal and placental insufficiency pregnancies.

A longitudinal and cross-sectional study of placental circulation between normal and placental insufficiency pregnancies.

Journal: Placenta

Published: September 05, 2023

Showing 1-8 of 8

Last Updated: 09/26/2026